Grade My Investments
HomeFree Stock Grades › LIVN

LivaNova PLC (LIVN) Stock Grade

LIVN · Healthcare

B+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$3.4B
P/E Ratio
38.8
Revenue Growth (YoY)
+10.7%
Net Margin
-17.5%
Return on Equity
Dividend Yield
None

About LivaNova PLC's fundamentals

LivaNova is a medical device company with a $3.4 billion market capitalization that generated 10.7% year-over-year revenue growth. However, the company is currently unprofitable, posting a net margin of -17.5% and reporting a net loss in its latest annual statement, which results in an unmeasurable return on equity. Despite the accounting losses, the company maintains positive free cash flow, suggesting its cash generation from operations exceeds its capital expenditures. The stock trades at a P/E ratio of 38.8 and does not pay a dividend.

Track LIVN free — no credit card required. Live grade + monthly AI report →